Hypervirulent Klebsiella pneumoniae ST23 producing OXA-48 in Switzerland

Int J Antimicrob Agents. 2021 Dec;58(6):106457. doi: 10.1016/j.ijantimicag.2021.106457. Epub 2021 Oct 24.

¹ Service of Hospital Preventive Medicine, Lausanne University hospital and University Hospital, Lausanne, Switzerland; Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), Universities of Fribourg and Lausanne, Switzerland.
² Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), Universities of Fribourg and Lausanne, Switzerland; Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; INSERM European Unit (IAME), University of Fribourg, Fribourg, Switzerland.
³ Service of Hospital Preventive Medicine, Lausanne University hospital and University Hospital, Lausanne, Switzerland.
⁴ Institute for Microbiology, Lausanne University hospital and University of Lausanne, Lausanne, Switzerland.
⁵ Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), Universities of Fribourg and Lausanne, Switzerland; Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; INSERM European Unit (IAME), University of Fribourg, Fribourg, Switzerland; Institute for Microbiology, Lausanne University hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: patrice.nordmann@unifr.ch.

No abstract available

Publication types